Category: Buy Revlimid online

Buy Revlimid online

Showing the single result

Buy Revlimid online

Revlimid is a prescription medicine used to treat the symptoms of Myelodysplastic Syndromes (MDS), Multiple Myeloma, Mantle Cell Lymphoma, Follicular Lymphoma and Marginal Zone Lymphoma. Revlimid may be used alone or with other medications.

Revlimid belongs to a class of drugs called Antineoplastics, Angiogenesis Inhibitor.

It is not known if Revlimid is safe and effective in children younger than 18 years of age.

What are the possible side effects of Revlimid?

Revlimid may cause serious side effects including:

  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • severe skin reaction,
  • fever,
  • sore throat,
  • burning in your eyes,
  • skin pain,
  • red or purple skin rash that spreads and causes blistering and peeling,
  • sudden numbness or weakness,
  • severe headache,
  • problems with speech or vision,
  • shortness of breath,
  • swelling or redness in your arm or leg,
  • chest pain or pressure,
  • pain spreading to your jaw or shoulder,
  • sweating,
  • chills,
  • swollen gums,
  • mouth sores,
  • skin sores,
  • easy bruising,
  • unusual bleeding,
  • swollen glands,
  • low fever,
  • rash,
  • pain,
  • lower back pain,
  • blood in your urine,
  • little or no urination,
  • numbness or tingly feeling around your mouth,
  • shortness of breath,
  • confusion, and
  • fainting

Get medical help right away, if you have any of the symptoms listed above.

The most common side effects of Revlimid include:

  • fever,
  • cough,
  • tiredness,
  • itching,
  • rash,
  • swelling,
  • nausea,
  • diarrhea, and
  • constipation

Tell the doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Revlimid. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

WARNING

EMBRYO-FETAL TOXICITY, HEMATOLOGIC TOXICITY, and VENOUS and ARTERIAL THROMBOEMBOLISM

Embryo-Fetal Toxicity

Do not use REVLIMID during pregnancy. Lenalidomide, a thalidomide analogue, caused limb abnormalities in a developmental monkey study. Thalidomide is a known human teratogen that causes severe life-threatening human birth defects. If lenalidomide is used during pregnancy, it may cause birth defects or embryo-fetal death. In females of reproductive potential, obtain 2 negative pregnancy tests before starting REVLIMID® treatment. Females of reproductive potential must use 2 forms of contraception or continuously abstain from heterosexual sex during and for 4 weeks after REVLIMID treatment [see WARNINGS AND PRECAUTIONS, and Medication Guide]. To avoid embryo-fetal exposure to lenalidomide, REVLIMID is only available through a restricted distribution program, the REVLIMID REMS® program.

Information about the REVLIMID REMS program is available at www.celgeneriskmanagement.com or by calling the manufacturer’s toll-free number 1-888-423-5436.

Hematologic Toxicity (Neutropenia and Thrombocytopenia)

REVLIMID can cause significant neutropenia and thrombocytopenia. Eighty percent of patients with del 5q myelodysplastic syndromes had to have a dose delay/reduction during the major study. Thirty-four percent of patients had to have a second dose delay/reduction. Grade 3 or 4 hematologic toxicity was seen in 80% of patients enrolled in the study. Patients on therapy for del 5q myelodysplastic syndromes should have their complete blood counts monitored weekly for the first 8 weeks of therapy and at least monthly thereafter. Patients may require dose interruption and/or reduction. Patients may require use of blood product support and/or growth factors [see DOSAGE AND ADMINISTRATION].

Venous and Arterial Thromboembolism

REVLIMID has demonstrated a significantly increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as risk of myocardial infarction and stroke in patients with multiple myeloma who were treated with REVLIMID and dexamethasone therapy. Monitor for and advise patients about signs and symptoms of thromboembolism. Advise patients to seek immediate medical care if they develop symptoms such as shortness of breath, chest pain, or arm or leg swelling. Thromboprophylaxis is recommended and the choice of regimen should be based on an assessment of the patient’s underlying risks [see WARNINGS AND PRECAUTIONS].

Lenalidomide is a cancer drug and is also known by its brand name, Revlimid. Lenalidomide also availalble in India under brand name Lenalid, wich sell by our website, we do not sell brand Revlimid, we can help to buy only Lenalidomide from Natco Pharma, with low india cost. Company Natco Pharma founded in 1981 year, wich manufactured Lenalid and many others anti-cancer medications. For example Cellgene wich manufactured brand Revlimid founded in 1986. So we can trust Natco Pharma not less that to Cellgene, this is two trusted

Open chat